نتائج البحث

Cabergoline Induced Pathological Gambling in an Adolescent with Prolactinoma

• Authors : Tercan U; İstanbul University, İstanbul Faculty of Medicine, Department of Pediatric Endocrinology, İstanbul, Türkiye; Sarban E

Subjects: Cabergoline*/Cabergoline*/Cabergoline*/adverse effects ; Prolactinoma*/Prolactinoma*/Prolactinoma*/drug therapy ; Pituitary Neoplasms*/Pituitary Neoplasms*/Pituitary Neoplasms*/drug therapy

• Source: Journal of clinical research in pediatric endocrinology [J Clin Res Pediatr Endocrinol] 2026 May 22; Vol. 18 (Suppl 1), pp. 64-69. Date of Electronic Publication: 2025 Jan 24.Publisher: Galenos Yayınevi Country of Publication: Turkey NLM ID: 101519456 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Management outcomes of prolactinoma: a retrospective study from Southern Iraq.

• Authors : Alobaidy HF; Al-Hassan Metabolism, Endocrine, and Diabetes Center, Karbala, Iraq.; Alidrisi HA

Subjects: Prolactinoma*/Prolactinoma*/Prolactinoma*/therapy ; Prolactinoma*/Prolactinoma*/Prolactinoma*/drug therapy ; Prolactinoma*/Prolactinoma*/Prolactinoma*/pathology

• Source: Journal of medicine and life [J Med Life] 2025 Sep; Vol. 18 (9), pp. 869-877.Publisher:

تفاصيل العنوان

Cholesterol-activated stress granules reduce the membrane localization of DRD2 and promote prolactinoma dopamine agonists resistance.

• Authors : Peng Y; Multidisciplinary Center for Pituitary Adenomas of Chongqing, Department of Neurosurgery, Xinqiao Hospital, Army Medical University, 183 Xinqiao Main Street, Shapingba District, Chongqing, China.; Yin H

Subjects: Prolactinoma*/Prolactinoma*/Prolactinoma*/metabolism ; Prolactinoma*/Prolactinoma*/Prolactinoma*/drug therapy ; Prolactinoma*/Prolactinoma*/Prolactinoma*/pathology

• Source: Acta neuropathologica communications [Acta Neuropathol Commun] 2025 Apr 25; Vol. 13 (1), pp. 84. Date of Electronic Publication: 2025 Apr 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101610673 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-5960

تفاصيل العنوان

Transcriptomic analysis of the anti-tumor effects of leflunomide in prolactinoma.

• Authors : Pei X; Department of Neurosurgery, Xinqiao Hospital, Army Medical University, Chongqing, 400037, China.; Peng Y

Subjects: Leflunomide*/Leflunomide*/Leflunomide*/pharmacology ; Prolactinoma*/Prolactinoma*/Prolactinoma*/drug therapy ; Prolactinoma*/Prolactinoma*/Prolactinoma*/genetics

• Source: Scientific reports [Sci Rep] 2025 Apr 05; Vol. 15 (1), pp. 11703. Date of Electronic Publication: 2025 Apr 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Giant prolactinoma with progressive cranial settling and central herniation: a case report.

• Authors : Shahbazi T; Neurosurgery Research Group (NRG), Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.; Abdollahi Yeganeh S

Subjects: Prolactinoma*/Prolactinoma*/Prolactinoma*/surgery ; Pituitary Neoplasms*/Pituitary Neoplasms*/Pituitary Neoplasms*/surgery ; Pituitary Neoplasms*/Pituitary Neoplasms*/Pituitary Neoplasms*/pathology

• Source: Journal of medical case reports [J Med Case Rep] 2024 Dec 22; Vol. 18 (1), pp. 604. Date of Electronic Publication: 2024 Dec 22.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium: Internet ISSN: 1752-1947

تفاصيل العنوان

Exploring retinal vessel density alterations in prolactinoma patients: Insights from OCTA imaging.

• Authors : Hayat SC; Department of Ophthalmology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.; Yilmaz YC

Subjects: Tomography, Optical Coherence*/Tomography, Optical Coherence*/Tomography, Optical Coherence*/methods ; Prolactinoma*/Prolactinoma*/Prolactinoma*/diagnosis ; Prolactinoma*/Prolactinoma*/Prolactinoma*/physiopathology

• Source: Indian journal of ophthalmology [Indian J Ophthalmol] 2024 Nov 01; Vol. 72 (Suppl 5), pp. S882-S886. Date of Electronic Publication: 2024 Oct 25.Publisher: Medknow Publications Country of Publication: India NLM ID: 0405376 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Elucidating Clinical Queries for Tailored Therapy in Patients with Prolactinoma.

• Authors : Lee MH; University of Medicine and Health Sciences, New York, NY, USA.; Hong JW

Subjects: Prolactinoma*/Prolactinoma*/Prolactinoma*/drug therapy ; Pituitary Neoplasms*/Pituitary Neoplasms*/Pituitary Neoplasms*/drug therapy ; Dopamine Agonists*/Dopamine Agonists*/Dopamine Agonists*/therapeutic use

• Source: Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2024 Dec; Vol. 39 (6), pp. 819-826. Date of Electronic Publication: 2024 Oct 14.Publisher: Korean Endocrine Society Country of Publication: Korea (South) NLM ID: 101554139 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Aggressive prolactinomas in men are associated with visual disturbances and pituitary hormone deficiencies.

• Authors : Díaz-López EJ; Department of Endocrinology and Nutrition , University Clinical Hospital of Santiago de Compostela , Compostela , Spain. .; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS) , Unidad de Enfermedades Tiroideas e Metabólicas (UETeM) University of Santiago de Compostela , Compostela , Spain. .

Subjects: Prolactinoma*/Prolactinoma*/Prolactinoma*/complications ; Prolactinoma*/Prolactinoma*/Prolactinoma*/pathology ; Prolactinoma*/Prolactinoma*/Prolactinoma*/blood

• Source: Scientific reports [Sci Rep] 2025 Nov 11; Vol. 15 (1), pp. 39497. Date of Electronic Publication: 2025 Nov 11.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight.

• Authors : Caprio S; Section of Endocrinology, Department of Medical, Surgical and Neurogical Sciences, University of Siena, Siena, Italy.; Pilli T

Subjects: Prolactinoma*/Prolactinoma*/Prolactinoma*/drug therapy ; Prolactinoma*/Prolactinoma*/Prolactinoma*/blood ; Insulin-Like Growth Factor I*/Insulin-Like Growth Factor I*/Insulin-Like Growth Factor I*/metabolism

• Source: BMC endocrine disorders [BMC Endocr Disord] 2024 Jun 20; Vol. 24 (1), pp. 94. Date of Electronic Publication: 2024 Jun 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101088676 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6823

تفاصيل العنوان

Ultra-rapid prolactin normalization with cabergoline in a premenopausal woman with epilepsy and giant prolactinoma.

• Authors : Pokem, Perrin Ngougni¹ (AUTHOR); Constantinescu, Stefan Matei² (AUTHOR); Cools, Hadrien¹ (AUTHOR)

• Source: JCEM Case Reports. May2026, Vol. 4 Issue 5, p1-5. 5p.

تفاصيل العنوان